To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Clinical trial NCT06481085 · COMPLETED

Trial details

NCT number: NCT06481085
Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-06-27
Primary completion: 2025-05-30
Enrollment: 324

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.